Reference
Nerrant E, et al. Severe bradycardia: An unreported adverse infusion-associated reaction (IAR) with alemtuzumab. Revue Neurologique 173: 175-176, No. 3, Mar 2017. Available from: URL: http://doi.org/10.1016/j.neurol.2017.02.008 - France
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1656, 25 (2017). https://doi.org/10.1007/s40278-017-31355-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-31355-y